NEWS
TOP: Russell Pearson before
and after treatment with Revita
duodenal mucosal resurfacing
(DMR). ABOVE: Fractyl Revita
Catheter, used in surgery.
NEWS
REPORT
A breakthrough treatment for Type 2 diabetes is now available
to self-paying patients at The Princess Grace Hospital, London.
New treatment for T2
R
evita is a minimally
invasive procedure
performed
endoscopically to
target the duodenum,
a precise area of the intestine that plays
a critical role in metabolic pathways,
including insulin resistance. It is a non-drug
and non-surgical alternative shown to enhance insulin
sensitivity, lower HbA1c and
create long-lasting improvements in blood
sugar control. Alongside a healthy diet
and exercise, one Revita treatment can
last up to 24 months or more and is ideal
for anyone with a busy lifestyle, where
taking daily medications can be a burden.
The Princess Grace Hospital in
London is the first medical facility to offer
Revita, a treatment that involves duodenal
mucosal resurfacing (DMR). It is provided
as part of a programme of care including
consultations and post-procedure
support, helping peo-ple to adjust to a
healthier lifestyle post-procedure, with
specialist follow-up appoint-ments for
diabetes and dietary advice, as needed.
It follows a series of global clinical trials
on the procedure, involving close to 300
participants, and including four NHS
hospitals. Research shows improved
overall insulin sensitivity, lowered HbA1c
(by nearly 1%), moderate weight loss,
improved liver health - more than 35%
reduction in liver fat and increased 'good'
(HDL) cholesterol.
Dr David Hopkins, Consultant
Physician and Diabetologist at King's
College Hospital and lead investigator in
the Revita-2 clinical trial, explains, "Revita
is a pioneering treatment which could
radically change the course of Type 2
diabetes. By targeting insulin resistance
in the duodenum - the root cause of
metabolic disease - the Revita procedure
has considerable benefits and may help
the person to avoid escalating drug
treatment."
Russell Pearson from Essex, pictured
above before and after his Revita
treatment, was one of the early clinical
trial patients in the UK, having undergone
the procedure in London three years ago.
He says, "Before my Revita procedure,
I was taking two diabetes tablets and
my GP was concerned I might have to
take insulin in the future. After Revita, my
blood sugar improved for the first time in
years, and I have also reduced my daily
medication. My recent blood test shows
my levels are now better than the prediabetic range."
Given time and further proof of
efficacy, it is hoped that this treatment
may become available on the NHS for
people that qualify.
www.discoverrevita.co.uk
revita.pgh@hcahealthcare.co.ukk/dmr" target="_blank" title="Visit www.hcahealthcare.co.uk/dmr">www.hcahealthcare.co.uk/dmr
To book a consultation with The Princess
Grace Hospital, email
Revita.PGH@hcahealthcare.co.uk